<?xml version="1.0" encoding="UTF-8"?><experiments api-version="3" api-revision="091015" version="3.0" revision="091015" total="1" total-samples="62" total-assays="62"><experiment><id>269791</id><accession>E-GEOD-17891</accession><secondaryaccession>GSE17891</secondaryaccession><name>Pervasive subtypes of pancreatic ductal adenocarcinoma (PDA) and their differing response to therapy</name><releasedate>2011-04-01</releasedate><lastupdatedate>2014-06-02</lastupdatedate><organism>Homo sapiens</organism><organism>Mus musculus</organism><experimenttype>transcription profiling by array</experimenttype><description><id/><text>Pancreatic ductal adenocarcinoma (PDA) carries a dismal prognosis and current treatments are only modestly effective. We present evidence that this variation is caused in part by recurrent, pervasive molecular differences between tumors. mRNA expression profiles measured using microdissected PDA clinical samples reveal three dominant subtypes of disease; epithelial, mesenchymal and acinar-like. The classical and quasi-mesenchymal subtypes are observed in human and mouse PDA cell lines. Importantly, responses to cytotoxics and KRAS depletion in human PDA cell lines differ substantially between subtypes, and in opposing directions. Integrated genomics implicate and functional studies support overexpression of the trancription factor GATA6 as a driver of the epithelial subtype. These results provide a molecular framework for evaluating the prospects of personalized treatment in PDA. RNA was extracted from archival patient FFPE PDA samples and hybridized on Affymetrix U133 plus 2.0 microarrays. The CEL files were processed using R based Bioconductor and normalized values were obtained using RMA.  RNA was extracted from human PDA cell line samples and hybridized on Affymetrix U133 plus 2.0 microarrays. The CEL files were processed using R based Bioconductor and normalized values were obtained using RMA.  RNA was extracted from mouse PDA cell lines and hybridized on Affymetrix Mouse 430a 2.0 microarrays. The CEL files were processed using R based Bioconductor and normalized values were obtained using RMA.</text></description><provider><contact>Eric A Collisson</contact><role/><email/></provider><provider><contact>Anguraj Sadanandam</contact><role>submitter</role><email>anguraj.sadanandam@epfl.ch</email></provider><provider><contact>Margaret Tempero</contact><role/><email/></provider><provider><contact>Douglas Hanahan</contact><role/><email/></provider><provider><contact>Anguraj Sadanandam</contact><role/><email/></provider><provider><contact>Joe W Gray</contact><role/><email/></provider><provider><contact>Peter Olson</contact><role/><email/></provider><bibliography><accession>21460848</accession><authors>Collisson EA, Sadanandam A, Olson P, Gibb WJ, Truitt M, Gu S, Cooc J, Weinkle J, Kim GE, Jakkula L, Feiler HS, Ko AH, Olshen AB, Danenberg KL, Tempero MA, Spellman PT, Hanahan D, Gray JW</authors><title>Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy.</title><doi>10.1038/nm.2344</doi></bibliography><samplecharacteristic><category>cell line</category><value>10.05</value><value>2.13</value><value>3.27</value><value>6.03</value><value>Capan1</value><value>Capan2</value><value>CFPac1</value><value>COLO357</value><value>Dan_G</value><value>HPAC</value><value>HPAF_II</value><value>HupT3</value><value>Miapaca2</value><value>Mpanc96</value><value>Panc1</value><value>pancreatic ductal adenocarcinoma cell line derived from p48-cre, kras, Ink4a/Arf mice</value><value>pancreatic ductal adenocarcinoma cell line derived from p48-cre, kras, p53 fl/wt mice</value><value>Suit2</value><value>SW1990</value><value>Tu8902</value><value>Tu8988S</value><value>Tu8988T</value></samplecharacteristic><samplecharacteristic><category>Organism</category><value>Homo sapiens</value><value>Mus musculus</value></samplecharacteristic><samplecharacteristic><category>organism part</category><value>ductal adenocarcinoma tumor</value></samplecharacteristic><experimentalvariable><name>CELL LINE</name><value>10.05</value><value>2.13</value><value>3.27</value><value>6.03</value><value>Capan1</value><value>Capan2</value><value>CFPac1</value><value>COLO357</value><value>Dan_G</value><value>HPAC</value><value>HPAF_II</value><value>HupT3</value><value>Miapaca2</value><value>Mpanc96</value><value>not specified</value><value>Panc1</value><value>pancreatic ductal adenocarcinoma cell line derived from p48-cre, kras, Ink4a/Arf mice</value><value>pancreatic ductal adenocarcinoma cell line derived from p48-cre, kras, p53 fl/wt mice</value><value>Suit2</value><value>SW1990</value><value>Tu8902</value><value>Tu8988S</value><value>Tu8988T</value></experimentalvariable><experimentalvariable><name>ORGANISM</name><value>Homo sapiens</value><value>Mus musculus</value></experimentalvariable><arraydesign><id>11119</id><accession>A-AFFY-44</accession><name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name><count>47</count><legacy_id>405156763</legacy_id></arraydesign><arraydesign><id>10904</id><accession>A-AFFY-36</accession><name>Affymetrix GeneChip Mouse Genome 430A 2.0 [Mouse430A_2]</name><count>15</count><legacy_id>447429329</legacy_id></arraydesign><protocol><id>698595</id><accession>P-GSE17891-11</accession></protocol><protocol><id>698594</id><accession>P-GSE17891-6</accession></protocol><protocol><id>698596</id><accession>P-GSE17891-7</accession></protocol><protocol><id>698591</id><accession>P-GSE17891-8</accession></protocol><protocol><id>698593</id><accession>P-GSE17891-9</accession></protocol><protocol><id>698589</id><accession>P-GSE17891-2</accession></protocol><protocol><id>698597</id><accession>P-GSE17891-3</accession></protocol><protocol><id>698598</id><accession>P-GSE17891-4</accession></protocol><protocol><id>698590</id><accession>P-GSE17891-5</accession></protocol><protocol><id>698592</id><accession>P-GSE17891-10</accession></protocol><protocol><id>698588</id><accession>P-GSE17891-1</accession></protocol><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>62</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>62</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>62</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>62</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>62</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>62</bioassays><isderived>0</isderived></bioassaydatagroup></experiment></experiments>